Arch Venture Management, LLC Portfolio Holdings

Arch Venture Management, LLC

  • $171 Million
  • Q2 2024

Arch Venture Management, LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $171 Million distributed in 9 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Beam Therapeutics Inc. with a value of $128M, Erasca, Inc. with a value of $26.1M, Verve Therapeutics, Inc. with a value of $9.8M, Gossamer Bio, Inc. with a value of $7.25M, and Unity Biotechnology, Inc. with a value of $0.

Examining the 13F form we can see an increase of $102M in the current position value, from $68.7M to 171M.

Arch Venture Management, LLC is based out at Chicago, IL

Below you can find more details about Arch Venture Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $171 Million
Healthcare: $171 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$299M
$9.8 Million 5.74% of portfolio
2,008,809
Q3 2022 Reduced 19.93%
$90.2M
$7.25 Million 4.25% of portfolio
8,055,916
Q3 2023 New

Summary

  • Portfolio
  • No. of Stocks 9
  • Current Value $171 Million
  • Prior Value $68.7 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 3 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Arch Venture Management, LLC Portfolio

Follow Arch Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arch Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arch Venture Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email